Santhera Pharmaceuticals Holding AG revenue reports
Santhera Pharmaceuticals Holding AG financial reports, Santhera Pharmaceuticals Holding AG annual revenue in 2024. When does Santhera Pharmaceuticals Holding AG report revenue?
Santhera Pharmaceuticals Holding AG total revenue, net income and dynamics of changes in Swiss franc today
Santhera Pharmaceuticals Holding AG current income in Swiss franc. Net revenue Santhera Pharmaceuticals Holding AG is now 3 616 500 Fr. Information about net revenue is taken from open sources. Net income Santhera Pharmaceuticals Holding AG - -17 916 000 Fr. Information about net income is used from open sources. Graph of finance company Santhera Pharmaceuticals Holding AG. The financial report chart shows the values from 30/09/2018 to 31/12/2020. Information on Santhera Pharmaceuticals Holding AG net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2020
3 616 500 Fr
-54.923 % ↓
-17 916 000 Fr
-
30/09/2020
3 616 500 Fr
-52.458 % ↓
-17 916 000 Fr
-
30/06/2020
3 887 500 Fr
-57.548 % ↓
-15 913 500 Fr
-
31/03/2020
3 887 500 Fr
-57.548 % ↓
-15 913 500 Fr
-
30/06/2019
9 157 500 Fr
-
-13 450 000 Fr
-
31/03/2019
9 157 500 Fr
-
-13 450 000 Fr
-
31/12/2018
8 023 000 Fr
-
-14 263 000 Fr
-
30/09/2018
7 607 000 Fr
-
-12 572 000 Fr
-
Show:
to
Santhera Pharmaceuticals Holding AG financial report charts
Dates of Santhera Pharmaceuticals Holding AG finance reports: 30/09/2018, 30/09/2020, 31/12/2020. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of Santhera Pharmaceuticals Holding AG is 31/12/2020. Gross profit Santhera Pharmaceuticals Holding AG is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Santhera Pharmaceuticals Holding AG is 2 459 000 Fr
Santhera Pharmaceuticals Holding AG quarterly report dates
Cost of revenue Santhera Pharmaceuticals Holding AG is the total cost of producing and distributing of products and services of a company. Cost of revenue Santhera Pharmaceuticals Holding AG is 1 157 500 Fr Total revenue Santhera Pharmaceuticals Holding AG refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Santhera Pharmaceuticals Holding AG is 3 616 500 Fr Operating income Santhera Pharmaceuticals Holding AG is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Santhera Pharmaceuticals Holding AG is -6 361 500 Fr
Net income Santhera Pharmaceuticals Holding AG is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Santhera Pharmaceuticals Holding AG is -17 916 000 Fr Current assets Santhera Pharmaceuticals Holding AG is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Santhera Pharmaceuticals Holding AG is 17 723 000 Fr Total assets Santhera Pharmaceuticals Holding AG refers to the total amount of assets owned by a person or entity. Total assets Santhera Pharmaceuticals Holding AG is 88 687 000 Fr
31/12/2020
30/09/2020
30/06/2020
31/03/2020
30/06/2019
31/03/2019
31/12/2018
30/09/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 459 000 Fr
2 459 000 Fr
2 830 500 Fr
2 830 500 Fr
7 879 000 Fr
7 879 000 Fr
6 927 000 Fr
6 442 000 Fr
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 157 500 Fr
1 157 500 Fr
1 057 000 Fr
1 057 000 Fr
1 278 500 Fr
1 278 500 Fr
1 096 000 Fr
1 165 000 Fr
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
3 616 500 Fr
3 616 500 Fr
3 887 500 Fr
3 887 500 Fr
9 157 500 Fr
9 157 500 Fr
8 023 000 Fr
7 607 000 Fr
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
9 157 500 Fr
9 157 500 Fr
8 023 000 Fr
7 607 000 Fr
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-6 361 500 Fr
-6 361 500 Fr
-12 946 500 Fr
-12 946 500 Fr
-11 217 000 Fr
-11 217 000 Fr
-14 253 000 Fr
-10 870 000 Fr
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-17 916 000 Fr
-17 916 000 Fr
-15 913 500 Fr
-15 913 500 Fr
-13 450 000 Fr
-13 450 000 Fr
-14 263 000 Fr
-12 572 000 Fr
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
7 332 000 Fr
7 332 000 Fr
8 844 000 Fr
8 844 000 Fr
9 662 500 Fr
9 662 500 Fr
11 142 000 Fr
8 244 000 Fr
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
9 978 000 Fr
9 978 000 Fr
16 834 000 Fr
16 834 000 Fr
20 374 500 Fr
20 374 500 Fr
22 276 000 Fr
18 477 000 Fr
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
17 723 000 Fr
17 723 000 Fr
36 554 000 Fr
36 554 000 Fr
38 472 000 Fr
38 472 000 Fr
43 083 000 Fr
45 465 000 Fr
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
88 687 000 Fr
88 687 000 Fr
100 074 000 Fr
100 074 000 Fr
106 092 000 Fr
106 092 000 Fr
110 294 000 Fr
78 772 000 Fr
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
12 411 000 Fr
12 411 000 Fr
19 353 000 Fr
19 353 000 Fr
12 698 000 Fr
12 698 000 Fr
21 971 000 Fr
19 654 000 Fr
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
27 229 000 Fr
27 229 000 Fr
19 709 000 Fr
11 828 000 Fr
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
96 838 000 Fr
96 838 000 Fr
82 465 000 Fr
73 969 000 Fr
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
91.28 %
91.28 %
74.77 %
93.90 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-6 354 000 Fr
-6 354 000 Fr
210 000 Fr
210 000 Fr
9 254 000 Fr
9 254 000 Fr
27 829 000 Fr
4 803 000 Fr
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-10 109 500 Fr
-10 109 500 Fr
-4 906 000 Fr
-10 805 000 Fr
Last revenue report of Santhera Pharmaceuticals Holding AG was 31/12/2020. According to last financial report total revenue in Santhera Pharmaceuticals Holding AG was 3 616 500 Swiss franc and changed by -54.923% since last year. Net income in Santhera Pharmaceuticals Holding AG was -17 916 000 Fr in last quartal, net income changes to 0%.
Current cash Santhera Pharmaceuticals Holding AG - the sum of all of the cash a company has on the date of report. Current cash Santhera Pharmaceuticals Holding AG is 12 411 000 Fr
Santhera Pharmaceuticals Holding AG stocks data
SANN.SW stock price
Santhera Pharmaceuticals Holding AG stock price today, SANN.SW stock quote.
